{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:10:11Z","timestamp":1791180611374,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T00:00:00Z","timestamp":1375660800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0069570","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T17:42:15Z","timestamp":1375724535000},"page":"e69570","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Headaches in Multiple Sclerosis Patients Might Imply an Inflammatorial Process"],"prefix":"10.1371","volume":"8","author":[{"given":"Jan","family":"M\u00f6hrke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kropp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe K.","family":"Zettl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Zettl UK, Stuve O, Patejdl R (2012) Immune-mediated CNS diseases: a review on nosological classification and clinical features. Autoimmunity reviews 11, 167\u2013173.","DOI":"10.1016\/j.autrev.2011.05.008"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Comabella M, Khoury SJ (2012) Immunopathogenesis of multiple sclerosis. Clinical Immunology 142, 2\u20138.","DOI":"10.1016\/j.clim.2011.03.004"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Mix E, Meyer-Rienecker H, Hartung HP, Zettl UK (2010) Animal models of multiple sclerosis-potentials and limitations. Prog Neurobiol 92, 386\u2013404.","DOI":"10.1016\/j.pneurobio.2010.06.005"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, <etal>et al<\/etal>.. (2010) A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis Ann Neurol 68(4), 477\u2013493.","DOI":"10.1002\/ana.22230"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, <etal>et al<\/etal>.. (2010) A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 68, 477\u2013493.","DOI":"10.1002\/ana.22230"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, <etal>et al<\/etal>.. (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130, 1089\u20131104.","DOI":"10.1093\/brain\/awm038"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Levy D (2009) Migraine pain, meningeal inflammation, and mast cells. Curr Pain Headache Rep 13, 237\u2013240.","DOI":"10.1007\/s11916-009-0040-y"},{"key":"ref8","unstructured":"IHS (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 Suppl 1, 9\u2013160."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Obermann M, Katsarava Z (2008) Epidemiology of unilateral headaches. Expert Rev Neurother 8, 1313\u20131320.","DOI":"10.1586\/14737175.8.9.1313"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Akerman S, Holland PR, Goadsby PJ (2011) Diencephalic and brainstem mechanisms in migraine. Nature reviews. Neuroscience 12, 570\u2013584.","DOI":"10.1038\/nrn3057"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Farkkila M, Diener HC, Geraud G, Lainez M, Schoenen J, <etal>et al<\/etal>.. (2012) Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurol 11, 405\u2013413.","DOI":"10.1016\/S1474-4422(12)70047-9"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"D&apos;Amico D, La Mantia L, Rigamonti A, Usai S, Mascoli N, <etal>et al<\/etal>.. (2004) Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia 24, 980\u2013984.","DOI":"10.1111\/j.1468-2982.2004.00790.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Kister I, Caminero AB, Herbert J, Lipton RB (2010) Tension-type headache and migraine in multiple sclerosis. Curr Pain Headache Rep 14, 441\u2013448.","DOI":"10.1007\/s11916-010-0143-5"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Chen Y (2009) Advances in the pathophysiology of tension-type headache: from stress to central sensitization. Curr Pain Headache Rep 13, 484\u2013494.","DOI":"10.1007\/s11916-009-0078-x"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Villani V, Prosperini L, Ciuffoli A, Pizzolato R, Salvetti M, <etal>et al<\/etal>.. (2008) Primary headache and multiple sclerosis: preliminary results of a prospective study. Neurol Sci 29 Suppl 1, S146\u2013148.","DOI":"10.1007\/s10072-008-0908-3"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"May A (2005) Cluster headache: pathogenesis, diagnosis, and management. Lancet 366, 843\u2013855.","DOI":"10.1016\/S0140-6736(05)67217-0"},{"key":"ref17","unstructured":"Gaul C, Diener HC, M\u00fcller OM (2011) Clusterkopfschmerz: Klinisches Bild und therapeutische Optionen. Dtsch Arztebl 108, 543\u2013549."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"May A, Bahra A, B\u00fcchel C, Frackowiak RS, Goadsby PJ (1998) Hypothalamic activation in cluster headache attacks. Lancet 352, 275\u2013278.","DOI":"10.1016\/S0140-6736(98)02470-2"},{"key":"ref19","unstructured":"Hautzinger M, Keller F, K\u00fchner C (2009) BDI-II. Beck-Depressions-Inventar. Revision. 2. Auflage., Pearson Assessment, Frankfurt."},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Morfeld M, Bullinger M, Nantke J, Br\u00e4hler E (2005) Die Version 2.0 des SF-36 Health Survey \u2013 Ergebnisse einer bev\u00f6lkerungsrepr\u00e4sentativen Studie. Sozial- und Pr\u00e4ventivmedizin\/Social and Preventive Medicine 50, 292\u2013300.","DOI":"10.1007\/s00038-005-4090-6"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, <etal>et al<\/etal>.. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d. Ann Neurol 58, 840\u2013846.","DOI":"10.1002\/ana.20703"},{"key":"ref22","unstructured":"Hautzinger M (2006) Beck Depressions-Inventar BDI II.Revision, Harcourt Test Services, Frankfurt."},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Pearson KX (1900) On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Philosophical Magazine Series 5 50, 157\u2013175.","DOI":"10.1080\/14786440009463897"},{"key":"ref24","unstructured":"Bortz J (2004) Statistik: f\u00fcr Human- und Sozialwissenschaftler Springer: Berlin."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, <etal>et al<\/etal>.. (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27, 193\u2013210.","DOI":"10.1111\/j.1468-2982.2007.01288.x"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Gee JR, Chang J, Dublin AB, Vijayan N (2005) The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache 45, 670\u2013677.","DOI":"10.1111\/j.1526-4610.2005.05136.x"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Nicoletti A, Patti F, Lo Fermo S, Liberto A, Castiglione A, <etal>et al<\/etal>.. (2008) Headache and multiple sclerosis: a population-based case-control study in Catania, Sicily. Cephalalgia 28, 1163\u20131169.","DOI":"10.1111\/j.1468-2982.2008.01662.x"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Putzki N, Pfriem A, Limmroth V, Yaldizli O, Tettenborn B, <etal>et al<\/etal>.. (2009) Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol 16, 262\u2013267.","DOI":"10.1111\/j.1468-1331.2008.02406.x"},{"key":"ref29","unstructured":"Yetimalar Y, Secil Y, Inceoglu AK, Eren S, Basoglu M (2008) Unusual primary manifestations of multiple sclerosis. N Z Med J 121, 47\u201359."},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Boneschi FM, Colombo B, Annovazzi P, Martinelli V, Bernasconi L, <etal>et al<\/etal>.. (2008) Lifetime and actual prevalence of pain and headache in multiple sclerosis. Mult Scler 14, 514\u2013521.","DOI":"10.1177\/1352458507085551"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"P\u00f6llmann W, Erasmus LP, Feneberg W, Then Bergh F, Straube A (2002) Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 59, 636\u2013639.","DOI":"10.1212\/WNL.59.4.636"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Schramm S, Obermann M, Katsavara Z, Diener HC, Moebus S, <etal>et al<\/etal>.. (2013) Epidemiological profiles of patients with chronic migraine and chronic tension-type headache. J Headache Pain 14, 40.","DOI":"10.1186\/1129-2377-14-40"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Dalakas MC (1994) High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology 44, 223\u2013226.","DOI":"10.1212\/WNL.44.2.223"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Wittstock M, Benecke R, Zettl UK (2003) Therapy with intravenous immunoglobulins: complications and side-effects. Eur Neurol 50, 172\u2013175.","DOI":"10.1159\/000073059"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Gold R, Wolinsky JS, Amato MP, Comi G (2010) Evolving expectations around early management of multiple sclerosis. Ther Adv Neurol Disord 3, 351\u2013367.","DOI":"10.1177\/1756285610385608"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Trojano M, Paolicelli D, Bellacosa A, Cataldo S (2003) The transition from relapsing-remitting MS to irreversible disability: clinical evaluation. Neurol Sci 24 Suppl 5, S268\u2013270.","DOI":"10.1007\/s10072-003-0171-6"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, <etal>et al<\/etal>.. (1989) The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 112 (Pt 6), 1419\u20131428.","DOI":"10.1093\/brain\/112.1.133"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Sormani MP, Bonzano L, Roccatagliata L, Mancardi GL, Uccelli A, <etal>et al<\/etal>.. (2010) Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach. Neurology 75, 302\u2013309.","DOI":"10.1212\/WNL.0b013e3181ea15aa"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Lassmann H (2011) Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer&apos;s disease. Journal of Neural Transmission 118, 747\u2013752.","DOI":"10.1007\/s00702-011-0607-8"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, <etal>et al<\/etal>.. (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132, 1175\u20131189.","DOI":"10.1093\/brain\/awp070"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Vacca G, Marano E, Brescia Morra V, Lanzillo R, De Vito M, <etal>et al<\/etal>.. (2007) Multiple sclerosis and headache co-morbidity. A case-control study. Neurol Sci 28, 133\u2013135.","DOI":"10.1007\/s10072-007-0805-1"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Kister I, Caminero AB, Monteith TS, Soliman A, Bacon TE, <etal>et al<\/etal>.. (2010) Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course. J Headache Pain 11, 417\u2013425.","DOI":"10.1007\/s10194-010-0237-9"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0069570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T07:48:57Z","timestamp":1563608937000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0069570"}},"subtitle":[],"editor":[{"given":"Sven G.","family":"Meuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,5]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0069570","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,5]]}}}